Nvidia vs. AMD vs. Cerebras: Which Is the Best AI Inference Stock to Buy Today?

The article argues the AI cycle is shifting from LLM training to inference, with Nvidia, AMD, and Cerebras competing for leadership in inference processors. It highlights AMD’s acquisition of MEXT as a cost-effective memory-management upgrade to reduce reliance on scarce/expensive HBM, and notes Cerebras’ faster but premium wafer-scale CS-3 systems (including a cited $20B OpenAI deal and an AWS partnership). Overall, it favors AMD as the best-positioned inference/agentic-AI winner, while framing Nvidia as attractive but less preferred at the moment.

Analysis

The real mechanism here is not “who has the fastest chip,” but who can win on cost per token once inference becomes the larger budget line. That favors vendors that reduce effective memory cost and simplify deployment, which is why AMD looks better positioned than the market may be assuming: if its software stack meaningfully stretches scarce HBM, it can take share in the price-sensitive middle of the market without needing to beat NVDA head-on on peak performance.

NVDA still owns the highest-probability default account base because CUDA lowers switching friction, but inference is a different buying behavior than training: buyers benchmark throughput per dollar, not developer mindshare. That makes NVDA’s mix more exposed to pricing pressure over the next 1-3 quarters, even if unit demand remains strong. The second-order winner is the cloud layer (AMZN) if it can monetize more serving cycles and higher utilization; the loser is any vendor that needs a premium, rack-level, all-in solution to participate.

CBRS is the highest-beta expression of the theme, but also the most fragile: the more customer-specific the deployment, the more binary the revenue stream. If OpenAI/AWS actually standardize it, the stock could re-rate hard; if not, it remains an expensive niche product with execution and concentration risk. Over 6-18 months, agentic AI matters because it should raise CPU attach rates, which is structurally constructive for AMD’s server franchise and mildly negative for pure-GPU narratives if GPU demand normalizes faster than expected.

Contrarian take: the market may be over-optimizing on raw inference speed and underweighting memory economics. If enterprise buyers prioritize total cost of ownership, AMD can gain share faster than NVDA’s moat narrative implies. The thesis is falsified if NVDA’s next two earnings prints show inference/rack revenue accelerating without margin dilution, or if AMD fails to translate the MEXT integration into visible design wins.

Key Decisions for Investors

• Long AMD / short NVDA, sized modestly, as a 1-3 month relative-value trade into the next two earnings cycles; thesis is AMD outperforms on cost-per-token and CPU attach, while NVDA’s inference mix faces more pricing pressure. Stop if NVDA prints materially faster inference growth with stable margins.
• Buy AMD call spreads 6-12 months out rather than outright stock if you want convexity on adoption of its inference stack; this expresses upside from share gains without paying full delta for the whole AI complex.
• Use AMZN as a secondary beneficiary on weakness: inference-heavy workloads should support AWS utilization and revenue density, so the better trade is to buy pullbacks in cloud monetizers rather than chase the most expensive chip names.
• Treat CBRS as a small, event-driven watchlist name only; initiate only if backlog/customer concentration data confirm repeatable demand. Otherwise, the risk/reward is too binary for core capital.
• If holding NVDA, tighten risk ahead of the next earnings print and watch for any sign that inference pricing is compressing gross margin; that is the key falsifier for the bull case.